Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25


Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants.

Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE.

AIDS Patient Care STDS. 2015 Mar;29(3):111-6. doi: 10.1089/apc.2014.0255. Epub 2015 Jan 23.


Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence.

Saberi P, Mayer K, Vittinghoff E, Naar-King S; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS Behav. 2015 Jan;19(1):93-103. doi: 10.1007/s10461-014-0806-z.


Individualised motivational counselling to enhance adherence to antiretroviral therapy is not superior to didactic counselling in South African patients: findings of the CAPRISA 058 randomised controlled trial.

van Loggerenberg F, Grant AD, Naidoo K, Murrman M, Gengiah S, Gengiah TN, Fielding K, Abdool Karim SS.

AIDS Behav. 2015 Jan;19(1):145-56. doi: 10.1007/s10461-014-0763-6.


Appreciating Reasons for Nonadherence in Women.

Okonsky JG, Webel A, Rose CD, Johnson M, Asher A, Cuca Y, Kaihura A, Hanson JE, Portillo CJ.

Health Care Women Int. 2015 Sep;36(9):1007-25. doi: 10.1080/07399332.2014.903952. Epub 2014 May 15.


Adherence in the CAPRISA 004 tenofovir gel microbicide trial.

Mansoor LE, Abdool Karim Q, Yende-Zuma N, MacQueen KM, Baxter C, Madlala BT, Grobler A, Abdool Karim SS.

AIDS Behav. 2014 May;18(5):811-9. doi: 10.1007/s10461-014-0751-x.


Empirical validation of the information-motivation-behavioral skills model of diabetes medication adherence: a framework for intervention.

Mayberry LS, Osborn CY.

Diabetes Care. 2014;37(5):1246-53. doi: 10.2337/dc13-1828. Epub 2014 Mar 5.


Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011.

Charania MR, Marshall KJ, Lyles CM, Crepaz N, Kay LS, Koenig LJ, Weidle PJ, Purcell DW; HIV/AIDS Prevention Research Synthesis (PRS) Team.

AIDS Behav. 2014 Apr;18(4):646-60. doi: 10.1007/s10461-013-0594-x. Review.


Increasing quality of life and reducing HIV burden: the PATH+ intervention.

Blank MB, Hennessy M, Eisenberg MM.

AIDS Behav. 2014 Apr;18(4):716-25. doi: 10.1007/s10461-013-0606-x.


A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.

Bassett IV, Giddy J, Chaisson CE, Ross D, Bogart LM, Coleman SM, Govender T, Robine M, Erlwanger A, Freedberg KA, Katz JN, Walensky RP, Losina E.

BMC Infect Dis. 2013 Aug 26;13:390. doi: 10.1186/1471-2334-13-390.


Effects of a Phone Call Intervention to Promote Adherence to Antiretroviral Therapy and Quality of Life of HIV/AIDS Patients in Baoshan, China: A Randomized Controlled Trial.

Huang D, Sangthong R, McNeil E, Chongsuvivatwong V, Zheng W, Yang X.

AIDS Res Treat. 2013;2013:580974. doi: 10.1155/2013/580974. Epub 2013 Jan 17.


Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel.

Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang LW, Gross R, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, Scott JD, Stirratt MJ, Remien RH, Simoni JM, Nachega JB.

Ann Intern Med. 2012 Jun 5;156(11):817-33, W-284, W-285, W-286, W-287, W-288, W-289, W-290, W-291, W-292, W-293, W-294. doi: 10.7326/0003-4819-156-11-201206050-00419. Epub 2012 Mar 5.


Technology-based self-care methods of improving antiretroviral adherence: a systematic review.

Saberi P, Johnson MO.

PLoS One. 2011;6(11):e27533. doi: 10.1371/journal.pone.0027533. Epub 2011 Nov 30. Review.


Pharmacists' strategies for promoting medication adherence among patients with HIV.

Kibicho J, Owczarzak J.

J Am Pharm Assoc (2003). 2011 Nov-Dec;51(6):746-55. doi: 10.1331/JAPhA.2011.10190.


Secondary prevention of HIV in the United States: past, current, and future perspectives.

Fisher JD, Smith LR, Lenz EM.

J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 2:S106-15. doi: 10.1097/QAI.0b013e3181fbca2f. Review.


A randomized controlled trial comparing the effects of counseling and alarm device on HAART adherence and virologic outcomes.

Chung MH, Richardson BA, Tapia K, Benki-Nugent S, Kiarie JN, Simoni JM, Overbaugh J, Attwa M, John-Stewart GC.

PLoS Med. 2011 Mar;8(3):e1000422. doi: 10.1371/journal.pmed.1000422. Epub 2011 Mar 1.


Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders.

Pop-Eleches C, Thirumurthy H, Habyarimana JP, Zivin JG, Goldstein MP, de Walque D, MacKeen L, Haberer J, Kimaiyo S, Sidle J, Ngare D, Bangsberg DR.

AIDS. 2011 Mar 27;25(6):825-34. doi: 10.1097/QAD.0b013e32834380c1.


Implementation of antiretroviral therapy adherence interventions: a realist synthesis of evidence.

Leeman J, Chang YK, Lee EJ, Voils CI, Crandell J, Sandelowski M.

J Adv Nurs. 2010 Sep;66(9):1915-30. doi: 10.1111/j.1365-2648.2010.05360.x. Review.


Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial.

Giordano TP, Bartsch G, Zhang Y, Tedaldi E, Absalon J, Mannheimer S, Thomas A, MacArthur RD.

AIDS Patient Care STDS. 2010 May;24(5):287-95. doi: 10.1089/apc.2009.0332.


A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA.

Sandelowski M, Voils CI, Chang Y, Lee EJ.

AIDS Care. 2009 Aug;21(8):953-66. doi: 10.1080/09540120802626212. Review.

Items per page

Supplemental Content

Write to the Help Desk